Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01870661
Other study ID # 035-13
Secondary ID
Status Withdrawn
Phase N/A
First received June 3, 2013
Last updated June 24, 2014
Start date May 2013
Est. completion date May 2014

Study information

Verified date June 2014
Source Beth Israel Medical Center
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Comparison of peripheral IV catheters inserted by ultrasound using the long axis vs. the short axis technique. Our hypothesis is that long axis ultrasound placement will increase the longevity of the IV catheter.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date May 2014
Est. primary completion date May 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- A patient who needs PIV access for intravenous medications and resuscitation either on a medical-surgical floor or in the ICU

- After floor team (including RN and/or house staff) and IV Nurse have attempted and failed or is not available

Exclusion Criteria:

- Need for vasopressors

- Need for TPN

- Need for hemodynamic monitoring

- Non English speaking patient

- Patients who are unable to consent

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Long axis IV placement with ultrasound
Peripheral IV placement with the ultrasound probe viewing the vessel in the long axis.
Short axis IV placement with ultrasound
Peripheral IV placement with the ultrasound probe viewing the vessel in the short axis.

Locations

Country Name City State
United States Beth Isreal Medical Center New York New York

Sponsors (1)

Lead Sponsor Collaborator
Beth Israel Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary catheter survival How many catheters survived for 3 days or as long as they are needed. 3 days Yes
Secondary Need for central venous access for 3 days Yes
Secondary success rate of peripheral IV using ultrasound assistance 30 minutes Yes
Secondary Complication rate 3 days Yes